These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35939656)
1. Differences between men and women in response to antiseizure medication use and the likelihood of developing treatment resistant epilepsy. Cepeda MS; Teneralli RE; Kern DM; Novak G Epilepsia Open; 2022 Dec; 7(4):598-607. PubMed ID: 35939656 [TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis. Janmohamed M; Hakeem H; Ooi S; Hakami S; Vu L; Perucca P; O'Brien TJ; Antonic-Baker A; Chen Z; Kwan P CNS Drugs; 2023 Jan; 37(1):13-30. PubMed ID: 36542274 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis. Fang T; Valdes E; Frontera JA Neurocrit Care; 2022 Feb; 36(1):248-258. PubMed ID: 34286461 [TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
7. First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy. van der Meer PB; Maschio M; Dirven L; Taphoorn MJB; Koekkoek JAF; Epilepsia; 2023 Jan; 64(1):162-169. PubMed ID: 36380710 [TBL] [Abstract][Full Text] [Related]
8. Effects on executive functions of antiepileptic monotherapy in pediatric age. Operto FF; Pastorino GMG; Mazza R; Carotenuto M; Roccella M; Marotta R; di Bonaventura C; Verrotti A Epilepsy Behav; 2020 Jan; 102():106648. PubMed ID: 31715510 [TBL] [Abstract][Full Text] [Related]
9. Multicenter Research Data of Epilepsy Management in Patients With Sturge-Weber Syndrome. Smegal LF; Sebold AJ; Hammill AM; Juhász C; Lo WD; Miles DK; Wilfong AA; Levin AV; Fisher B; Ball KL; Pinto AL; Comi AM; Pediatr Neurol; 2021 Jun; 119():3-10. PubMed ID: 33813331 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST). Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C; CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770 [TBL] [Abstract][Full Text] [Related]
11. Pregabalin add-on for drug-resistant focal epilepsy. Panebianco M; Bresnahan R; Hemming K; Marson AG Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157 [TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813 [TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008 [TBL] [Abstract][Full Text] [Related]
15. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274 [TBL] [Abstract][Full Text] [Related]
16. Response to first antiseizure medication in patients diagnosed with epilepsy. Hersi H; Saarinen JT; Raitanen J; Peltola J Acta Neurol Scand; 2021 Jul; 144(1):67-75. PubMed ID: 33835491 [TBL] [Abstract][Full Text] [Related]
17. Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications: A Retrospective Cohort Study. Lawal OD; Meador KJ; Hume AL; Wen X Neurology; 2023 Sep; 101(10):e1083-e1096. PubMed ID: 37407266 [TBL] [Abstract][Full Text] [Related]
18. Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan. Chiang KL; Liang CY; Hsieh LP; Chien LN Seizure; 2021 Dec; 93():145-153. PubMed ID: 34768177 [TBL] [Abstract][Full Text] [Related]
19. Long-term safety, efficacy, and tolerability of levetiracetam in pediatric patients with epilepsy in Uygur, China: A retrospective analysis. Zhao T; Li HJ; Yu J; Wang TT; Feng J; Ma L; Sun L; Sun Y; Yu LH Epilepsy Behav; 2021 Jul; 120():108010. PubMed ID: 33964540 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims. Shcherbakova N; Rascati K; Brown C; Lawson K; Novak S; Richards KM; Yoder L CNS Drugs; 2014 Nov; 28(11):1047-58. PubMed ID: 25086640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]